Disease Markers

Disease Markers / 2019 / Article

Corrigendum | Open Access

Volume 2019 |Article ID 4025694 | 2 pages | https://doi.org/10.1155/2019/4025694

Corrigendum to “Serum Procalcitonin Levels in Acute Encephalopathy with Biphasic Seizures and Late Reduced Diffusion”

Received18 Apr 2019
Accepted22 Apr 2019
Published13 Dec 2019

In the article titled “Serum Procalcitonin Levels in Acute Encephalopathy with Biphasic Seizures and Late Reduced Diffusion” [1], there are errors that should be updated as follows: (1)In Abstract, () should be (), () should be (), and (79% and 100%) should be (100% and 80%)(2)In Section 3.2 in Results, “a sensitivity of 79% and a specificity of 100%” should be “a sensitivity of 100% and specificity of 80%”(3)The figures’ and tables’ captions are incomplete. They should be updated as follows:

Figure 1 PCT/CRP ratio in each disease group. AESD: acute encephalopathy with biphasic seizures and late reduced diffusion; CRP: C-reactive protein; FS: febrile seizures; PCT: procalcitonin; SIRS: systemic inflammatory response syndrome. PCT/CRP ratio = PCT level (ng/mL)/CRP level (mg/dL). Data for the FS and AESD groups are from this study; other data is from Nakanishi et al.

Figure 2 PCT/CRP ratio in FS and AESD. AESD: acute encephalopathy with biphasic seizures and late reduced diffusion; CRP: C-reactive protein; FS, febrile seizures; PCT: procalcitonin. .

Figure 3 Time course of PCT and CRP after onset in AESD. CRP: C-reactive protein; mPSL pulse: methyl prednisolone pulse therapy; PCT: procalcitonin. Follow-up after diagnosis of acute encephalopathy with biphasic seizures and late reduced diffusion and start of intervention. Data are presented as the .

Table 1 Patient characteristics of AESD and FS. AESD: acute encephalopathy with biphasic seizures and late reduced diffusion; FS: febrile seizures; HHV-6: human herpesvirus-6; hMPV: human metapneumovirus. All AESD specimens were subjected to blood culture, and results were all negative.

Table 2 PCT, CRP, and inflammatory cytokine of AESD and FS. AESD: acute encephalopathy with biphasic seizures and late reduced diffusion; CRP: C-reactive protein; FS: febrile seizures; PCT: procalcitonin. Data are presented as the . The ratio was calculated using a CRP value of 0.15 when it is below 0.15.

References

  1. Y. Fujii, M. Yashiro, M. Yamada et al., “Serum procalcitonin levels in acute encephalopathy with biphasic seizures and late reduced diffusion,” Disease Markers, vol. 2018, Article ID 2380179, 4 pages, 2018. View at: Publisher Site | Google Scholar

Copyright © 2019 Yosuke Fujii et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

259 Views | 155 Downloads | 0 Citations
 PDF  Download Citation  Citation
 Download other formatsMore
 Order printed copiesOrder

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at help@hindawi.com to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19.